Ginsenoside Compound K Attenuates Metastatic Growth of Hepatocellular Carcinoma, which Is Associated with the Translocation of Nuclear Factor-κB p65 and Reduction of Matrix Metalloproteinase-2/9

Abstract

The intestinal metabolite of ginseng saponin, compound K (CK), has various chemopreventive and chemotherapeutic activities, including anti-tumor activity. However, the functional mechanisms through which CK attenuates metastatic growth in hepatocellular carcinoma (HCC) remain unclear. Here, using multiple in vitro and in vivo models, we reported that CK strongly attenuated colony formation, adhesion, and invasion of HCC cells in vitro and dramatically inhibited spontaneous HCC metastatic growth in vivo. At the molecular level, immunofluorescence and Western blotting analysis confirmed that inhibition of metastatic growth of HCC induced by CK treatment caused a time-dependent decrease in nuclear NF-κB p65 and a concomitant increase in cytosolic NF-κB p65, indicating that CK suppressed the activation of the NF-κB pathway. Meanwhile, our study showed that the inhibition of matrix metalloproteinase2/9 (MMP2/9) expression caused by CK treatment was associated with NF-κB p65 nuclear export. Taken together, our results not only revealed that NF-κB p65 nuclear export and the reduction of MMP2/9 expression were associated with the metastatic inhibition induced by CK, but also suggested that CK may become a potential cytotoxic drug in the prevention and treatment of HCC.

Key words

compound K - ginsenoside - hepatocellular carcinoma - matrix metalloproteinase‐2/9 - NF‐κB p65

References

• 1 Wakabayashi C, Hasegawa H, Murata J, Saiki I. In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration.  Oncol Res. 1997;  9 411-417
• 2 Hasegawa H, Sung J H, Matsumiya S, Uchiyama M. Main ginseng saponin metabolites formed by intestinal bacteria.  Planta Med. 1996;  62 453-457
• 3 Kim do Y, Yuan H D, Chung I K, Chung S H. Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells.  J Agric Food Chem. 2009;  57 1532-1537
• 4 Lee B H, Lee S J, Hur J H, Lee S, Sung J H, Huh J D, Moon C K. In vitro antigenotoxic activity of novel ginseng saponin metabolites formed by intestinal bacteria.  Planta Med. 1998;  64 500-503
• 5 Hasegawa H, Sung J H, Matsumiya S, Uchiyama M, Inouye Y, Kasai R, Yamasaki K. Reversal of daunomycin and vinblastine resistance in multidrug-resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids.  Planta Med. 1995;  61 409-413
• 6 Hasegawa H, Sung J H, Huh J H. Ginseng intestinal bacterial metabolite IH901 as a new anti-metastatic agent.  Arch Pharm Res. 1997;  20 539-544
• 7 Choo M K, Sakurai H, Kim D H, Saiki I. A ginseng saponin metabolite suppresses tumor necrosis factor-alpha-promoted metastasis by suppressing nuclear factor-kappaB signaling in murine colon cancer cells.  Oncol Rep. 2008;  19 595-600
• 8 Ming Y L, Song G, Chen L H, Zheng Z Z, Chen Z Y, Ouyang G L, Tong Q X. Anti-proliferation and apoptosis induced by a novel intestinal metabolite of ginseng saponin in human hepatocellular carcinoma cells.  Cell Biol Int. 2007;  31 1265-1273
• 9 Fokas E, Engenhart-Cabillic R, Daniilidis K, Rose F, An H X. Metastasis: the seed and soil theory gains identity.  Cancer Metastasis Rev. 2007;  26 705-715
• 10 Lynch C C, Matrisian L M. Matrix metalloproteinases in tumor-host cell communication.  Differentiation. 2002;  70 561-573
• 11 Fingleton B. Matrix metalloproteinases: roles in cancer and metastasis.  Front Biosci. 2006;  11 479-491
• 12 Van Waes C. Nuclear factor-kappaB in development, prevention, and therapy of cancer.  Clin Cancer Res. 2007;  13 1076-1082
• 13 Di Maio M, De Maio E, Perrone F, Pignata S, Daniele B. Hepatocellular carcinoma: systemic treatments.  J Clin Gastroenterol. 2002;  35 S109-S114
• 14 Song G, Ouyang G, Mao Y B, Ming Y L, Bao S, Hu T H. Osteopontin promotes metastatic growth of gastric cancer by augmenting cell survival and invasion through Akt-mediated HIF-1α up-regulation and MMP9 activation.  J Cell Mol Med. 2009;  13 1706-1718
• 15 Song G, Mao Y B, Cai Q F, Yao L M, Ouyang G L, Bao S D. Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis via activating p 53 and regulating apoptosis-related proteins.  Braz J Med Biol Res. 2005;  38 1791-1798
• 16 Song G, Chen G G, Chau D K, Miao J, Lai P B S. Bid exhibits S phase checkpoint activation and plays a pro-apoptotic role in response to etoposide-induced DNA damage in hepatocellular carcinoma cells.  Apoptosis. 2008;  13 693-701
• 17 Yeh H C, Lin S M, Chen M F, Pan T L, Wang P W, Yeh C T. Evaluation of serum matrix metalloproteinase (MMP)-9 to MMP-2 ratio as a biomarker in hepatocellular carcinoma.  Hepatogastroenterology. 2010;  57 98-102
• 18 Li Y, Tang Z Y, Ye S L, Liu Y K, Chen J, Xue Q, Gao D M, Bao W H. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.  World J Gastroenterol. 2001;  7 630-636
• 19 Zhang G X, He B, Weber G F. Growth factor signaling induces metastasis genes in transformed cells: molecular connection between Akt kinase and osteopontin in breast cancer.  Mol Cell Biol. 2003;  23 6507-6519
• 20 Zeng Z S, Cohen A M, Guillem J G. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis.  Carcinogenesis. 1999;  20 749-755
• 21 Futakuchi M, Ogawa K, Tamano S, Takahashi S, Shirai T. Suppression of metastasis by nuclear factor kappaB inhibitors in an in vivo lung metastasis model of chemically induced hepatocellular carcinoma.  Cancer Sci. 2004;  95 18-24
• 22 Abiru S, Nakao K, Ichikawa T, Migita K, Shigeno M, Sakamoto M, Ishikawa H, Hamasaki K, Nakata K, Eguchi K. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells.  Hepatology. 2002;  35 1117-1124